Nanologica AB Total Liabilities

Latest as of March 2026: Skr164.82 Million SEK ≈ $17.74 Million USD

Nanologica AB total liabilities. Based on the latest financial reports, Nanologica AB (NICA) has total liabilities worth Skr164.82 Million SEK (≈ $17.74 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Nanologica AB asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Nanologica AB (2012–2025)

Total liabilities of Nanologica AB from 2012 to 2025. This chart illustrates how Nanologica AB's total liabilities have evolved over time, based on quarterly financial data.

Nanologica AB Competitors by Total Liabilities

The table below lists competitors of Nanologica AB ranked by their total liabilities.

Company	Country	Total Liabilities
Garanti Yatirim Ortakligi AS IS:GRNYO	Turkey	TL4.55 Million
Westbond Enterprises Corp V:WBE	Canada	CA$4.47 Million
Homebiogas Ltd TA:HMGS	Israel	ILA2.20 Million
Orexo AB ST:ORX	Sweden	Skr243.30 Million
Hiremii Ltd AU:HMI	Australia	AU$4.74 Million
Utilico Emerging Markets Ltd LSE:UEM	UK	GBX25.52 Million
ECS Botanics Holdings Ltd AU:ECS	Australia	AU$9.11 Million
Battery Age Minerals Ltd AU:BM8	Australia	AU$2.63 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Nanologica AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Nanologica AB (NICA) total assets.

Liquidity & Leverage Metrics

Nanologica AB Total Liabilities Ratios Explained

Nanologica AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.15	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.69	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nanologica AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nanologica AB (2012–2025)

The table below shows the annual total liabilities of Nanologica AB from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr65.47 Million ≈ $7.05 Million	-5.10%
2024-12-31	Skr68.99 Million ≈ $7.42 Million	-13.03%
2023-12-31	Skr79.33 Million ≈ $8.54 Million	-2.49%
2022-12-31	Skr81.36 Million ≈ $8.76 Million	+74.13%
2021-12-31	Skr46.72 Million ≈ $5.03 Million	-12.48%
2020-12-31	Skr53.38 Million ≈ $5.74 Million	+39.87%
2019-12-31	Skr38.16 Million ≈ $4.11 Million	+259.34%
2018-12-31	Skr10.62 Million ≈ $1.14 Million	-55.70%
2017-12-31	Skr23.98 Million ≈ $2.58 Million	+143.71%
2016-12-31	Skr9.84 Million ≈ $1.06 Million	+14.02%
2015-12-31	Skr8.63 Million ≈ $928.58K	-24.54%
2014-12-31	Skr11.43 Million ≈ $1.23 Million	+252.85%
2013-12-31	Skr3.24 Million ≈ $348.74K	+20.11%
2012-12-31	Skr2.70 Million ≈ $290.36K	--

About Nanologica AB

ST:NICA Sweden Biotechnology

Market Cap

$5.66 Million

Skr52.60 Million SEK

Market Cap Rank

#28258 Global

#620 in Sweden

Share Price

Skr0.16

Change (1 day)

-5.33%

52-Week Range

Skr0.16 - Skr1.68

All Time High

Skr19.15